Position in SNY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,431,997
-$182,803 QoQ
Shares Held
80,450
+7.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#146
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cardinal Capital Management holds $99,250,544 across 9 Drug Manufacturers - General names. SNY ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,505 | $31,790,894 | |
| 2 | JNJ |
Johnson & Johnson
|
114,813 | $29,159,057 | |
| 3 | MRK |
Merck & Co., Inc.
|
96,235 | $12,366,197 | |
| 4 | NVS |
Novartis AG
|
49,670 | $7,784,282 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
105,075 | $6,054,421 | |
| 6 | SNY |
Sanofi
This page
|
80,450 | $3,431,997 | |
| 7 | GSK |
GSK plc
|
62,101 | $3,255,334 | |
| 8 | PFE |
Pfizer Inc
|
124,537 | $2,998,850 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,431,997 | 80,450 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $3,614,800 | 75,027 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $3,570,242 | 73,674 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $3,437,670 | 72,832 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $3,432,039 | 71,042 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $3,826,961 | 69,004 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $3,318,465 | 68,805 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $3,891,350 | 67,523 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $3,230,704 | 66,585 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $3,139,365 | 64,596 | Shares | Sole | 2024-07-12 | |
| 2023-12-31 | $2,926,809 | 58,854 | Shares | Sole | 2024-07-12 | |
| 2023-09-30 | $3,146,146 | 58,653 | Shares | Sole | 2024-07-12 | |
| 2023-06-30 | $3,111,161 | 57,721 | Shares | Sole | 2024-07-12 | |
| 2023-03-31 | $3,199,242 | 58,788 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $2,863,811 | 59,133 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $2,260,707 | 59,461 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $3,004,951 | 60,063 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $3,071,569 | 59,828 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $2,902,994 | 57,944 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,779,643 | 57,657 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $3,040,430 | 57,737 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $2,838,657 | 57,393 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $2,749,999 | 56,596 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $2,798,783 | 55,786 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $2,826,740 | 55,372 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $2,709,284 | 61,969 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||